Clinical Trial Update: A Clinical Trial of TQH3906 Capsules in Healthy Volunteers [Phase 1]

View source ↗

Summary

A Phase 1 study of TQH3906 capsules in healthy volunteers has completed, evaluating safety and pharmacokinetics for potential use in psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• TQH3906 capsules

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | Conditions: Psoriasis | Phase 1 | Status: COMPLETED